| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 20,4 k € | -35.1% | 31,4 k € | +98.4% | 15,8 k € | -65.3% | 45,6 k € | +58.9% | 28,7 k € | +1194.7% | -2,6 k € | -112.9% | 20,2 k € | +56.5% | 12,9 k € | -10.8% | 14,5 k € | +157.0% | 5,6 k € | -83.3% | 33,8 k € | |
| EBITDA | 19,8 k € | -35.8% | 30,9 k € | +103.3% | 15,2 k € | -66.2% | 45,0 k € | +60.1% | 28,1 k € | +970.8% | -3,2 k € | -116.9% | 19,1 k € | +52.7% | 12,5 k € | -9.7% | 13,8 k € | +164.6% | 5,2 k € | -84.0% | 32,7 k € | |
| Operating profit | 17,1 k € | -41.2% | 29,2 k € | +107.9% | 14,0 k € | -68.4% | 44,3 k € | +57.8% | 28,1 k € | +800.3% | -4,0 k € | -121.9% | 18,3 k € | +286.8% | 4,7 k € | -26.7% | 6,5 k € | +385.2% | -2,3 k € | -110.7% | 21,1 k € | |
| Profit/loss | 10,2 k € | -46.9% | 19,2 k € | +174.6% | 7,0 k € | -75.2% | 28,2 k € | +60.4% | 17,6 k € | +383.3% | -6,2 k € | -153.5% | 11,6 k € | +472.0% | 2,0 k € | -44.1% | 3,6 k € | +226.5% | -2,9 k € | -120.6% | 13,9 k € | |
| Equity | 110,3 k € | +10.2% | 100,1 k € | +23.7% | 80,9 k € | +9.4% | 74,0 k € | +61.4% | 45,8 k € | +62.1% | 28,3 k € | -18.0% | 34,5 k € | +50.6% | 22,9 k € | +9.7% | 20,9 k € | +21.0% | 17,2 k € | -14.2% | 20,1 k € | |
| Total assets | 121,0 k € | +8.8% | 111,2 k € | +3.7% | 107,2 k € | +10.3% | 97,1 k € | +60.1% | 60,7 k € | +32.7% | 45,7 k € | -16.3% | 54,6 k € | +37.4% | 39,7 k € | -22.7% | 51,4 k € | -2.5% | 52,7 k € | -17.0% | 63,5 k € | |
| Cash | 82,5 k € | -2.6% | 84,7 k € | +0.3% | 84,5 k € | +29.5% | 65,2 k € | +25.9% | 51,8 k € | +83.4% | 28,2 k € | -35.6% | 43,9 k € | +197.8% | 14,7 k € | -44.8% | 26,7 k € | +30.7% | 20,4 k € | -39.7% | 33,9 k € | |
| Debts | 7,6 k € | -4.1% | 7,9 k € | -65.9% | 23,3 k € | +0.6% | 23,1 k € | +58.0% | 14,6 k € | -16.2% | 17,4 k € | -13.3% | 20,1 k € | +19.5% | 16,8 k € | -44.9% | 30,5 k € | -13.8% | 35,4 k € | -18.5% | 43,4 k € | |
Private limited company · Kampenhout · incorporated on 29/04/2013
Private limited company profitable and well capitalised.
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
| Unit no. | Name | Location |
|---|---|---|
| 2219945166 | Clinical Trial Advising Bureau | Dijkstraat 11, 1820 Steenokkerzeel |
Clinical Trial Advising Bureau is a Private limited company incorporated in 2013. Its main activity is: Activités des laboratoires médicaux. Its registered office is in Kampenhout.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette